Dashboard
Manage Tickers

ONC BeiGene, Ltd.

Nasdaq beigene.com


$ 310.43 $ -3.51 (-1.12 %)    

Thursday, 23-Oct-2025 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 613.78 $ 0.00 (0 %)
DIA $ 468.29 $ 0.00 (0 %)
SPY $ 674.14 $ 0.00 (0 %)
TLT $ 91.37 $ 0.00 (0 %)
GLD $ 373.70 $ 0.00 (0 %)
$ 310.03
$ 310.21
$ 308.82 x 9
$ 313.37 x 100
-- - --
$ 170.99 - $ 355.30
205,992
na
34.11B
$ 1.00
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-06-2025 06-30-2025 10-Q
2 05-07-2025 03-31-2025 10-Q
3 02-27-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-07-2024 06-30-2024 10-Q
6 05-08-2024 03-31-2024 10-Q
7 02-26-2024 12-31-2023 10-K
8 11-09-2023 09-30-2023 10-Q
9 08-02-2023 06-30-2023 10-Q
10 05-04-2023 03-31-2023 10-Q
11 02-27-2023 12-31-2022 10-K
12 11-09-2022 09-30-2022 10-Q
13 08-08-2022 06-30-2022 10-Q
14 05-09-2022 03-31-2022 10-Q
15 02-28-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-05-2021 06-30-2021 10-Q
18 05-06-2021 03-31-2021 10-Q
19 02-25-2021 12-31-2020 10-K
20 11-05-2020 09-30-2020 10-Q
21 08-06-2020 06-30-2020 10-Q
22 05-11-2020 03-31-2020 10-Q
23 03-02-2020 12-31-2019 10-K
24 11-12-2019 09-30-2019 10-Q
25 08-08-2019 06-30-2019 10-Q
26 05-09-2019 03-31-2019 10-Q
27 02-28-2019 12-31-2018 10-K
28 11-08-2018 09-30-2018 10-Q
29 08-09-2018 06-30-2018 10-Q
30 05-09-2018 03-31-2018 10-Q
31 02-28-2018 12-31-2017 10-K
32 11-13-2017 09-30-2017 10-Q
33 08-09-2017 06-30-2017 10-Q
34 05-10-2017 03-31-2017 10-Q
35 03-22-2017 12-31-2016 10-K
36 11-10-2016 09-30-2016 10-Q
37 08-10-2016 06-30-2016 10-Q
38 05-12-2016 03-31-2016 10-Q
39 03-30-2016 12-31-2015 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
Morgan Stanley Maintains Overweight on BeO...
10/20/2025 15:25:30

Morgan Stanley analyst Sean Laaman maintains BeOne Medicines (NASDAQ:ONC) with a Overweight and raises the price target from...

whats-going-on-with-summit-therapeutics-stock-on-monday
What's Going On With Summit Therapeutics S...
10/20/2025 14:05:00

Summit Therapeutics shares Phase 3 data showing ivonescimab cut cancer progression risk by 40% and plans BLA submission in late...

Core News & Articles
Beone Medicines Announced The Presentation...
10/20/2025 10:10:02

Core News & Articles
The FDA Has Granted Breakthrough Therapy D...
10/13/2025 10:02:54

The decision by the FDA to grant sonrotoclax BTD and participation in Project Orbis was based on data from the BGB-11417-201 st...

Core News & Articles
Where BeOne Medicines Stands With Analysts
10/08/2025 18:00:49

Core News & Articles
JP Morgan Maintains Overweight on BeOne Me...
10/08/2025 17:33:30

JP Morgan analyst Jessica Fye maintains BeOne Medicines (NASDAQ:ONC) with a Overweight and raises the price target from $345...

Core News & Articles
Analyst Expectations For BeOne Medicines's...
09/18/2025 12:01:19

Core News & Articles
Barclays Initiates Coverage On BeOne Medic...
09/18/2025 11:18:09

Barclays analyst Peter Lawson initiates coverage on BeOne Medicines (NASDAQ:ONC) with a Overweight rating and announces Pric...

Core News & Articles
12 Health Care Stocks Moving In Wednesday'...
09/10/2025 12:11:03

wayfair-united-therapeutics-and-ciena-are-among-the-top-10-large-cap-gainers-last-week-sep-1-sep5-are-the-others-in-your-portfolio-corrected
Wayfair, United Therapeutics, And Ciena Ar...
09/07/2025 14:30:00

These ten large-cap stocks were top performers last week. Are they a part of your portfolio?

air-lease-ionis-pharmaceuticals-arrowhead-pharmaceuticals-and-other-big-stocks-moving-higher-on-tuesday
Air Lease, Ionis Pharmaceuticals, Arrowhea...
09/02/2025 14:41:45

Core News & Articles
Market-Moving News for September 2nd
09/02/2025 11:23:26

ONC: 9% | BeOne Medicines shares are trading higher after the company last week announced topline results from a Phase 1/2 stud...

why-carisma-therapeutics-shares-are-trading-higher-by-133-here-are-20-stocks-moving-premarket
Why Carisma Therapeutics Shares Are Tradin...
09/02/2025 09:28:56

beone-medicines-stock-gains-momentum-with-early-stage-trial-success-for-pretreated-lymphoma-patients
BeOne Medicines Stock Gains Momentum With ...
08/29/2025 14:16:02

BeOne Medicines reported positive Phase 1/2 results for sonrotoclax in relapsed or refractory mantle cell lymphoma, with regula...

affirm-posts-better-than-expected-earnings-joins-ambarella-iren-petco-health-and-wellness-and-other-big-stocks-moving-higher-on-friday
Affirm Posts Better-Than-Expected Earnings...
08/29/2025 13:56:35

Core News & Articles
BeOne Medicines' Sonrotoclax Achieves ORR ...
08/29/2025 10:05:29

Core News & Articles
BeOne's TEVIMBRA Wins EU Approval for Lung...
08/27/2025 10:02:34

BeOne Medicines Ltd. (NASDAQ:ONC, HKEX: 06160, SSE: 688235))), a global oncology company, today announced that the European Com...

Core News & Articles
The European Commission Has Approved BeOne...
08/27/2025 10:02:34

The EC approval is based on results from the Phase 3 RATIONALE-315 trial. The preplanned final analysis of RATIONALE-315 demons...

beone-cashes-in-on-amgens-cancer-drug-royalties-in-multibillion-dollar-pharma-tie-up
BeOne Cashes In On Amgen's Cancer Drug Roy...
08/25/2025 17:19:29

BeOne Medicines will sell global Imdelltra royalties to Royalty Pharma for up to $950 million while retaining rights to other o...

Core News & Articles
BeOne Medicines Agrees To Sell Its Royalty...
08/25/2025 10:07:02

Under the terms of the agreement, BeOne will receive an upfront payment of $885 million, with the option to sell remaining roya...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION